IPSC

CENTURY THERAPEUTICS INC

IPSC·15673T100·US·Common Stock·Healthcare - Biotechnology-13D/G

IPSC (CENTURY THERAPEUTICS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($40.1M), RTW INVESTMENTS, LP ($19.7M), Point72 Asset Management, L.P. ($13.5M). Net institutional sentiment: Bullish.

44
Holders
Avg rating(8 Elite)
$145.2M
Total Value
79% (47)
Fund Consensus
33 buying - 9 selling
IPSCSmart Money Verdict
View all
Held by 44 funds
8 elite
Who's Trading
InsiderRGRussotti GregorySell $6KJun 12, 2026
InsiderCDCarr DouglasSell $4KJun 12, 2026
InsiderRGRussotti GregorySell $1KJun 8, 2026
InsiderCDCarr DouglasSell $525.64Jun 8, 2026
ActivistRTW Investments, LPRTW Investments, LP7.1%May 15, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.3.3%May 15, 2026
InsiderCDCarr DouglasSell $618.02May 4, 2026
InsiderRGRussotti GregorySell $26KMar 12, 2026
InsiderCDCarr DouglasSell $18KMar 12, 2026
InsiderRGRussotti GregorySell $1KMar 9, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
17.8M$40.1M0.4%-1.32%
48
New
8.7M$19.7M0.2%-1.32%
47
Increased
6M(+0.1%)$13.5M0.0%+124.84%
28
New
5.7M$12.9M0.0%-1.32%
39
New
5M$11.3M0.0%-1.32%
39
Increased
4.7M(+664.6%)$10.5M0.0%+9.77%
45
Increased
3.8M(+106.1%)$8.6M0.0%+35.63%
44
New
3M$6.9M0.0%-1.32%
38
Increased
2.4M(+58.5%)$5.4M0.0%+73.25%
39
Increased
1.5M(+153.3%)$3.4M0.0%+26.79%
43
Increased
1.3M(+185.4%)$2.9M0.0%-44.22%
42
Decreased
906,827(-32.8%)$2M0.0%+127.66%
0
New
692,963$1.6M0.0%-1.32%
35
New
673,584$1.5M0.0%-1.32%
35
Increased
386,723(+203.4%)$873,9940.0%-9.83%
27
Increased
230,820(+119.7%)$521,6530.0%-45.79%
39
Increased
226,687(+352.4%)$512,3130.0%+17.90%
39
New
210,482$475,6890.0%-1.32%
33
Increased
145,099(+275x)$327,9240.0%-1.12%
26
Increased
120,232(+120.2Kx)$271,7240.0%-1.32%
38

Showing 1-20 of 47

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used